101 related articles for article (PubMed ID: 12152115)
1. Incidence and determinants of sildenafil (dis)continuation: the Dutch cohort of sildenafil users.
Souverein PC; Egberts AC; Meuleman EJ; Urquhart J; Leufkens HG
Int J Impot Res; 2002 Aug; 14(4):259-65. PubMed ID: 12152115
[TBL] [Abstract][Full Text] [Related]
2. What to learn about sildenafil in the treatment of erectile dysfunction from 3-year clinical experience.
Jiann BP; Yu CC; Tsai JY; Wu TT; Lee YH; Huang JK
Int J Impot Res; 2003 Dec; 15(6):412-7. PubMed ID: 14671659
[TBL] [Abstract][Full Text] [Related]
3. Long-term intracavernous therapy responders can potentially switch to sildenafil citrate after radical prostatectomy.
Raina R; Lakin MM; Agarwal A; Ausmundson S; Montague DK; Zippe CD
Urology; 2004 Mar; 63(3):532-7; discussion 538. PubMed ID: 15028452
[TBL] [Abstract][Full Text] [Related]
4. Patterns of use of sildenafil among commercially insured adults in the United States: 1998-2002.
Delate T; Simmons VA; Motheral BR
Int J Impot Res; 2004 Aug; 16(4):313-8. PubMed ID: 14973524
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy and safety of sildenafil in elderly patients with erectile dysfunction.
Fujisawa M; Sawada K
Arch Androl; 2004; 50(4):255-60. PubMed ID: 15277003
[TBL] [Abstract][Full Text] [Related]
6. High dose sildenafil citrate as a salvage therapy for severe erectile dysfunction.
McMahon CG
Int J Impot Res; 2002 Dec; 14(6):533-8. PubMed ID: 12494291
[TBL] [Abstract][Full Text] [Related]
7. An open-label, randomized, flexible-dose, crossover study to assess the comparative efficacy and safety of sildenafil citrate and apomorphine hydrochloride in men with erectile dysfunction.
Eardley I; Wright P; MacDonagh R; Hole J; Edwards A
BJU Int; 2004 Jun; 93(9):1271-5. PubMed ID: 15180621
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of sildenafil as the first-step therapeutic tool for Japanese patients with erectile dysfunction.
Ochiai A; Naya Y; Soh J; Ishida Y; Mizutani Y; Kawauchi A; Fujiwara T; Miki T
Int J Impot Res; 2005; 17(4):339-42. PubMed ID: 15829991
[TBL] [Abstract][Full Text] [Related]
9. A comparative, crossover study of the efficacy and safety of sildenafil and apomorphine in men with evidence of arteriogenic erectile dysfunction.
Perimenis P; Gyftopoulos K; Giannitsas K; Markou SA; Tsota I; Chrysanthopoulou A; Athanasopoulos A; Barbalias G
Int J Impot Res; 2004 Feb; 16(1):2-7. PubMed ID: 14963464
[TBL] [Abstract][Full Text] [Related]
10. Compliance of sildenafil treatment for erectile dysfunction and factors affecting it.
Jiann BP; Yu CC; Su CC; Tsai JY
Int J Impot Res; 2006; 18(2):146-9. PubMed ID: 16094412
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of sildenafil citrate in men with erectile dysfunction and chronic heart failure.
Katz SD; Parker JD; Glasser DB; Bank AJ; Sherman N; Wang H; Sweeney M
Am J Cardiol; 2005 Jan; 95(1):36-42. PubMed ID: 15619391
[TBL] [Abstract][Full Text] [Related]
12. Rechallenge prior sildenafil nonresponders.
Jiann BP; Yu CC; Su CC; Huang JK
Int J Impot Res; 2004 Feb; 16(1):64-8. PubMed ID: 14963473
[TBL] [Abstract][Full Text] [Related]
13. Patterns of switching phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction: results from the Erectile Dysfunction Observational Study.
Hatzichristou D; Haro JM; Martin-Morales A; von Keitz A; Riley A; Bertsch J; Belger M; Wolka AM; Beardsworth A;
Int J Clin Pract; 2007 Nov; 61(11):1850-62. PubMed ID: 17850306
[TBL] [Abstract][Full Text] [Related]
14. [Viagra is first choice preparation in the treatment of erectile dysfunction. Access to a variety of methods makes individual treatment possible].
Hedelin H; Jacobsson L
Lakartidningen; 2000 May; 97(21):2616-7. PubMed ID: 10881522
[TBL] [Abstract][Full Text] [Related]
15. Success of sildenafil for erectile dysfunction in men treated with brachytherapy or external beam radiation for prostate cancer.
Shemtov OM; Radomski SB; Crook J
Can J Urol; 2004 Dec; 11(6):2450-5. PubMed ID: 15636671
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of sildenafil citrate (Viagra) for the treatment of erectile dysfunction in men in Egypt and South Africa.
Levinson IP; Khalaf IM; Shaeer KZ; Smart DO
Int J Impot Res; 2003 Apr; 15 Suppl 1():S25-9. PubMed ID: 12825106
[TBL] [Abstract][Full Text] [Related]
17. Increasing incidence and importance of HIV/AIDS and gonorrhea among men aged >/= 50 years in the US in the era of erectile dysfunction therapy.
Karlovsky M; Lebed B; Mydlo JH
Scand J Urol Nephrol; 2004; 38(3):247-52. PubMed ID: 15204381
[TBL] [Abstract][Full Text] [Related]
18. Sildenafil citrate (Viagra) for the treatment of erectile dysfunction in Nigerian men.
Osegbe DN; Shittu OB; Aghaji AE; Onyemelukwe GC; Dogo D; Dikko AA
Int J Impot Res; 2003 Apr; 15 Suppl 1():S15-8. PubMed ID: 12825104
[TBL] [Abstract][Full Text] [Related]
19. Nitrate cessation profiles in men wishing to use sildenafil citrate.
Müller A; Shelton J; Parker M; Guhring P; Mulhall JP
Urology; 2007 May; 69(5):946-9. PubMed ID: 17482940
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular risk among men seeking help for erectile dysfunction.
Frantzen J; Speel TG; Kiemeney LA; Meuleman EJ
Ann Epidemiol; 2006 Feb; 16(2):85-90. PubMed ID: 16226038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
